Medtronic(MDT) - 2026 Q3 - Earnings Call Transcript

Medtronic (NYSE:MDT) Q3 2026 Earnings call February 17, 2026 08:00 AM ET Speaker2We look forward to bringing this unique catheter to the U.S. Beyond CAS, we're also making material progress with Symplicity Spyral for hypertension and UltraViva for urge urinary incontinence. Symplicity delivers a one-time, durable, minimally invasive treatment for hypertension and represents one of our largest growth drivers. Now, this is going to be a contributor for years to come, given the 18 million U.S. patients with un ...